Clarity Pharmaceuticals (CLRPF) Q1 2026 Earnings

25FebConfirmed
Q3 2024
Q1 2025
Q3 2025
Q1 2026
-0.1
-0.08
-0.06
-0.03

Details

Expected EPS
-0.05511485
Actual EPS
-0.10208925
Surprise EPS
-0.05
Surprise Percent
+85.23%

Description

Clarity Pharmaceuticals (CLRPF) has reported earnings of -0.10208925 per share for Q1 2026.

0 Comments

Share your thoughts